SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 53.85-4.5%Jan 9 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biomaven who started this subject10/20/2000 11:51:45 AM
From: keokalani'nui  Read Replies (1) of 52153
 
Returning to trickle down, picks and shovels.

I'm sure everyone has noticed the solid earnings reports by Biacore (today), ABIO, Waters (today), Compugen, Quiagen, et.al.,.....the steady upward improvement in business conditions seems widespread (20%-30% sales growth for the bigger ones, and higher for the others may become a phenomena). Caliper gets an upgrade and explodes, same with IVGN. Healthy, almost robust, all the way around.

Not sure what my point is here, but I remember Beckman Instruments during the difficult market conditions in the 70s....you would maybe not have noticed it in the present, but if you let it go and looked back after several years you would have had that damn-I'm-smart-why-didn't-I-buy-more feeling.

--Wilder
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext